{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:30:16Z","timestamp":1789421416859,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,3,15]],"date-time":"2008-03-15T00:00:00Z","timestamp":1205539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s10620-008-0225-y","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T17:10:01Z","timestamp":1205514601000},"page":"2778-2783","source":"Crossref","is-referenced-by-count":28,"title":["JAK2V617F Mutation in Patients with Portal Vein Thrombosis"],"prefix":"10.1007","volume":"53","author":[{"given":"Yusuf","family":"Bayraktar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Harmanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"B\u00fcy\u00fckasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ibrahim","family":"Shorbagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul Hasegeli","family":"Sungur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemaliye Akyerli","family":"Boylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytemiz","family":"G\u00fcrgey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhun","family":"Balkanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,15]]},"reference":[{"key":"225_CR1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","volume":"120","author":"B Condat","year":"2001","unstructured":"Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D (2001) Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 120:490\u2013497","journal-title":"Gastroenterology"},{"key":"225_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2002-23206","volume":"22","author":"SK Sarin","year":"2002","unstructured":"Sarin SK, Agarwal SR (2002) Extrahepatic portal vein obstruction. Semin Liver Dis 22:43\u201358","journal-title":"Semin Liver Dis"},{"key":"225_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.1087","volume":"67","author":"A G\u00fcrgey","year":"2001","unstructured":"G\u00fcrgey A, Haznedaroglu IC, Egesel T, B\u00fcy\u00fckasik Y, Ozcebe OI, Sayinalp N, Dundar SV, Bayraktar Y (2001) Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis. Am J Hematol 67:107\u2013111","journal-title":"Am J Hematol"},{"key":"225_CR4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004836-200001000-00013","volume":"30","author":"T Egesel","year":"2000","unstructured":"Egesel T, B\u00fcy\u00fckasik Y, Dundar SV, G\u00fcrgey A, Kirazli S, Bayraktar Y (2000) The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. J Clin Gastroenterol 30:66\u201371","journal-title":"J Clin Gastroenterol"},{"key":"225_CR5","first-page":"858","volume":"92","author":"Y Bayraktar","year":"1997","unstructured":"Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd-Chiari syndrome: a common complication of Beh\u00e7et\u2019s disease. Am J Gastroenterol 92:858\u2013862","journal-title":"Am J Gastroenterol"},{"key":"225_CR6","first-page":"1476","volume":"90","author":"Y Bayraktar","year":"1995","unstructured":"Bayraktar Y, Balkanci F, Kansu E, Dundar S, Uzunalimoglu B, Kayhan B, Telatar H, Gurakar A, Van Thiel DH (1995) Cavernous transformation of the portal vein: a common manifestation of Beh\u00e7et\u2019s disease. Am J Gastroenterol 90:1476\u20131479","journal-title":"Am J Gastroenterol"},{"key":"225_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","volume":"31","author":"MH Denninger","year":"2000","unstructured":"Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Bri\u00e8re J, Valla D (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31:587\u2013591","journal-title":"Hepatology"},{"key":"225_CR8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/gut.49.5.720","volume":"49","author":"HL Janssen","year":"2001","unstructured":"Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE, Rosendaal FR, van Hoek B (2001) Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 49:720\u2013724","journal-title":"Gut"},{"key":"225_CR9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0016-5085(88)90567-7","volume":"94","author":"D Valla","year":"1988","unstructured":"Valla D, Casadevall N, Huisse MG, Tulliez M, Grange JD, Muller O, Binda T, Varet B, Rueff B, Benhamou JP (1988) Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 94:1063\u20131069","journal-title":"Gastroenterology"},{"key":"225_CR10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-103-3-329","volume":"103","author":"D Valla","year":"1985","unstructured":"Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, Maillard JN, Pariente EA, Leporrier M, Rueff B, Muller O, Benhamou J-P (1985) Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in\u00a0vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 103:329\u2013334","journal-title":"Ann Intern Med"},{"key":"225_CR11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0168-8278(00)80259-7","volume":"32","author":"DC Valla","year":"2000","unstructured":"Valla DC, Condat B (2000) Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 32:865\u2013871","journal-title":"J Hepatol"},{"key":"225_CR12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-996117","volume":"23","author":"V Stefano De","year":"1997","unstructured":"De Stefano V, Teofili L, Leone G, Michiels JJ (1997) Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 23:411\u2013418","journal-title":"Semin Thromb Hemost"},{"key":"225_CR13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.2005.05490.x","volume":"129","author":"Y Chait","year":"2005","unstructured":"Chait Y, Condat B, Cazals-Hatem D, Rufat P, Atmani S, Chaoui D, Guilmin F, Kiladjian JJ, Plessier A, Denninger MH, Casadevall N, Valla D, Bri\u00e8re JB (2005) Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol 129:553\u2013560","journal-title":"Br J Haematol"},{"key":"225_CR14","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292\u20132302","journal-title":"Blood"},{"key":"225_CR15","first-page":"14","volume-title":"Polycythemia vera and the myeloproliferative disorders","author":"P Peterson","year":"1995","unstructured":"Peterson P, Wasserman LR (1995) The natural history of polycythemia vera. In: Wasserman LR, Berk PD, Berlin NI (eds) Polycythemia vera and the myeloproliferative disorders. WB Saunders, Philadelphia, pp 14\u201321"},{"key":"225_CR16","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.gastro.2006.04.008","volume":"130","author":"RK Patel","year":"2006","unstructured":"Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, G\u00e4ken J, Wendon J, Heaton ND, Mufti GJ (2006) Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 130:2031\u20132038","journal-title":"Gastroenterology"},{"key":"225_CR17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood.V68.5.996.996","volume":"68","author":"F Lemoine","year":"1986","unstructured":"Lemoine F, Najman A, Baillou C, Stachowiak J, Boffa G, Aegerter P, Douay L, Laporte JP, Gorin NC, Duhamel G (1986) A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia. Blood 68:996\u20131002","journal-title":"Blood"},{"key":"225_CR18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR; Cancer Genome Project (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054\u20131061","journal-title":"Lancet"},{"key":"225_CR19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D\u2019Andrea A, Fr\u00f6hling S, D\u00f6hner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387\u2013397","journal-title":"Cancer Cell"},{"key":"225_CR20","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic JP, Staerk J, Delhommeau F, Lacout C, Gar\u00e7on L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144\u20131148","journal-title":"Nature"},{"key":"225_CR21","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779\u20131790","journal-title":"N Engl J Med"},{"key":"225_CR22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"JS Levine","year":"2002","unstructured":"Levine JS, Branch W, Rausch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752\u2013763","journal-title":"N Engl J Med"},{"key":"225_CR23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mcg.0000225635.52780.47","volume":"41","author":"O Harmanci","year":"2007","unstructured":"Harmanci O, Ersoy O, G\u00fcrgey A, B\u00fcy\u00fckasik Y, Gedikoglu G, Balkanci F, Sivri B, Bayraktar Y (2007) The etiologic distribution of thrombophilic factors in chronic portal vein thrombosis. J Clin Gastroenterol 41:521\u2013527","journal-title":"J Clin Gastroenterol"},{"key":"225_CR24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3748\/wjg.v12.i8.1273","volume":"28","author":"O Harmanci","year":"2006","unstructured":"Harmanci O, B\u00fcy\u00fckasik Y, Kirazli S, Balkanci F, Bayraktar Y (2006) Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol 28:1273\u20131277","journal-title":"World J Gastroenterol"},{"key":"225_CR25","first-page":"89","volume":"13","author":"T Egesel","year":"2002","unstructured":"Egesel T, Unsal I, Bayraktar Y (2002) Antiphospholipid antibodies and lipoprotein (a) as etiologic or contributory factors in patients with idiopathic cavernous transformation of portal vein. Turk J Gastroenterol 13:89\u201393","journal-title":"Turk J Gastroenterol"},{"key":"225_CR26","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/hep.21435","volume":"44","author":"M Primignani","year":"2006","unstructured":"Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell\u2019Era A, Bucciarelli P, Mannucci PM (2006) Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 44:1528\u20131534","journal-title":"Hepatology"},{"key":"225_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1538-7836.2006.02277.x","volume":"5","author":"D Colaizzo","year":"2007","unstructured":"Colaizzo D, Amitrano L, Tiscia GL, Scenna G, Grandone E, Guardascione MA, Brancaccio V, Margaglione M (2007) The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost 5:55\u201361","journal-title":"J Thromb Haemost"},{"key":"225_CR28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","volume":"5","author":"V Stefano De","year":"2007","unstructured":"De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P, Sica S, Leone G (2007) Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 5:708\u2013714","journal-title":"J Thromb Haemost"},{"key":"225_CR29","first-page":"4229","volume":"26","author":"KH Ko","year":"2006","unstructured":"Ko KH, Kim NK, Yim DJ, Hong SP, Park PW, Rim KS, Kim S, Hwang SG (2006) Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population. Anticancer Res 26:4229\u20134233","journal-title":"Anticancer Res"},{"key":"225_CR30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.leukres.2006.01.016","volume":"30","author":"P Bolufer","year":"2006","unstructured":"Bolufer P, Barragan E, Collado M, Cervera J, L\u00f3pez JA, Sanz MA (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30:1471\u20131491","journal-title":"Leuk Res"},{"key":"225_CR31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/hmg\/ddm055","volume":"16","author":"RA Hubner","year":"2007","unstructured":"Hubner RA, Lubbe S, Chandler I, Houlston RS (2007) MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer. Hum Mol Genet 16:1072\u20131077","journal-title":"Hum Mol Genet"},{"key":"225_CR32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","volume":"128","author":"MA Elliott","year":"2005","unstructured":"Elliott MA, Tefferi A (2005) Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 128:275\u2013290","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"225_CR33","first-page":"54","volume":"24","author":"T Barbui","year":"2007","unstructured":"Barbui T (2007) The targets of therapy in polycythemia vera and thrombocythemia. Turk J Hematol 24(Suppl 1):54","journal-title":"Turk J Hematol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-008-0225-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0225-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T04:02:06Z","timestamp":1588478526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-008-0225-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,15]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["225"],"URL":"https:\/\/doi.org\/10.1007\/s10620-008-0225-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,15]]}}}